Slider Versus Tensioner Neural Mobilization Techniques in Carpal Tunnel Syndrome
Comparative Effects of Slider Versus Tensioner Median Nerve Mobilization in Patients With Carpal Tunnel Syndrome
neural mobilization techniques in carpal tunnel syndrome
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Thirty patients with CTS will be randomly allocated to two equal groups of 15. Group A will receive slider median nerve mobilization techniques and Group B received tensioners median nerve mobilization techniques , twice a week for 10 weeks
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Mohammed Hegazy
- Phone Number: 0566169893
- Email: m.hegazy@psau.edu.sa
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis of Alzheimer's Disease
- Must be able to swallow tablets
Exclusion Criteria:
- received physiotherapy or a steroid injection for CTS in the previous 3 months
- have CTS secondary to a chronic systemic disease such as diabetes mellitus, hypothyroidism or rheumatoid arthritis
- had previous wrist surgery
- have cervical radiculopathy or severe polyneuropathy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: group A
slider median nerve mobilization tecnique |
patients in group A recieve slider median nerve mobilization |
|
Experimental: group b
tensioner median nerve mobilization techniques |
patients in group recieve tensioner median nerve mobilization techniques |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pain intensity
Time Frame: 10 weeks
|
pain intensity will be measured by visual analogue scale |
10 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
functional disability
Time Frame: 10 weeks
|
it will be assessed by the arabic version of DASH questionnaire |
10 weeks
|
|
hand grip strength
Time Frame: 10 WEEKS
|
it will be assessed by HHD |
10 WEEKS
|
|
Pressure pain threshold
Time Frame: 10 weeks
|
It will be assessed by pressure algometry |
10 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Arman S, Menekseoglu AK, Sezgin B, Ozgur B, Capan N, Oral A. The effects of virtual reality-mediated tendon and nerve gliding exercises in the conservative management of carpal tunnel syndrome: a double-blind randomized placebo controlled trial. Eur J Phys Rehabil Med. 2024 Jun;60(3):458-469. doi: 10.23736/S1973-9087.24.08432-6. Epub 2024 Mar 29.
- Beddaa H, Kably B, Marzouk B, Mouhi I, Marfak A, Azemmour Y, Bouzekraoui Alaoui I, Birouk N. The effectiveness of the median nerve neurodynamic mobilisation techniques in women with mild or moderate bilateral carpal tunnel syndrome: A single-blind clinical randomised trial. S Afr J Physiother. 2022 Nov 30;78(1):1823. doi: 10.4102/sajp.v78i1.1823. eCollection 2022.
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RHPT/026/026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.